Citigroup advice for Vertex Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| January 09, 2020 | Citigroup | Vertex Pharma | Buy | 265.00 USD | 14.47 % |
Advice details
New York - Op 09 jan herhalen de analisten van Citigroup hun koopadvies voor Vertex Pharma (ISIN: US92532F1003 / Mnemo: VRTX). Het 12-maands koersdoel wordt opwaarts bijgesteld van 225.0 USD naar 265.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 